This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Albrecht Lauefer: Innovator in Recombinant Mycobacterium Technology
Introduction
Albrecht Lauefer is a notable inventor based in Germany. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for immune response elicitation.
Latest Patents
Albrecht Lauefer holds a patent titled "Combination Of A Recombinant Mycobacterium Comprising A Nucleic Acid Encoding A Phagolysosomal Escape Peptide And An Immune Response Eliciting Biologically Active Agent." This invention relates to a combination that includes a bacterial cell containing a recombinant nucleic acid molecule that encodes a phagolysosomal escape peptide or polypeptide, along with a biologically active agent.
Career Highlights
Lauefer is associated with Vakzine Projekt Management GmbH, where he applies his expertise in recombinant technology. His work focuses on advancing the understanding and application of immune response mechanisms.
Collaborations
He collaborates with notable colleagues such as Bernd Eisele and Leander Grode, contributing to a dynamic research environment that fosters innovation.
Conclusion
Albrecht Lauefer's work in recombinant mycobacterium technology exemplifies the intersection of science and innovation. His contributions are paving the way for advancements in immunology and biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile